Takeda to obtain exclusive worldwide rights to develop, manufacture and commercialize Antibody Drug Conjugates (ADC) using a panel of selected antibodies developed by Innate MARSEILLE, France–(BUSINESS WIRE)–#immunotherapy–Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) today announced that it has entered into an exclusive license agreement with Takeda under which Innate grants Takeda exclusive worldwide rights … [Read more…]

– New joint venture will conduct production control – TOKYO–(BUSINESS WIRE)–Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) and SCIVAX Co., Ltd. have entered into a capital and operational alliance regarding a foundry business designed to mass-produce nanoimprinted products. A production control joint venture, Nanoimprint Solutions Co., Ltd., (Nanosol) was established on April 3, 2023. … [Read more…]

TAIPEI, Taiwan–(BUSINESS WIRE)–REGiMMUNE Limited (REGiMMUNE), a biotech company focused on creating innovative immunotherapies for immune disorders and cancer, and San Fu Biotech (SFB), a subsidiary of San Fu Chemical Co., Ltd. (4755.TW) have entered a licensing agreement to develop and commercialize RGI-2001 for the prophylaxis of acute Graft-versus-host disease (aGvHD) in major Asian countries. RGI-2001, … [Read more…]

TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, today announced the filing of its Annual Report on Form 20-F for the year ended December … [Read more…]

CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (NASDAQ: ATHX) today announced financial results for the three and 12 months ended December 31, 2022, and provided a business update. Fourth Quarter 2022 and Recent Corporate and Operational Highlights Largely completed the company’s restructuring initiative with the goal of significantly reducing expenses, conserving cash, improving focus and making Athersys more attractive … [Read more…]

Conference Call Scheduled for April 3, 2023, at 9:00 a.m. Eastern Time SAN ANTONIO–(BUSINESS WIRE)–#BIAF—bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and 12 months ended December 31, 2022. Financial Highlights … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#COVID19–After it was reported that Chinese researchers released “a trove of new genetic data” that can potentially help discern the origin of the COVID-19 pandemic, AIDS Healthcare Foundation (AHF) expressed that while it is a step in the right direction, a full investigation cannot be conducted until China releases all available data it … [Read more…]

Revenue up 73% to $20.1 Million MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a global leading provider of patented, scientifically and clinically proven surface and air pathogen elimination and disinfection technologies (fixed, mobile, and HVAC), LED lighting products and premium hotel furnishings, announces today its financial results for the … [Read more…]

EMERYVILLE, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants, including lead product candidate NPM-119 for the treatment of patients with type 2 diabetes, today reported financial results for the fourth quarter and full year ended December 31, 2022, and provided a business update. According to … [Read more…]

Very promising preclinical results of the apoA-I biovector in an acute inflammation model Development of safe corticoids to limit traditional corticoid-related side effects when used in AMD or DME Project to separate the ophthalmology activities and change the name of IRIS Pharma Holding to APOGEYE Pharma Access here the full press release TOULOUSE, France & … [Read more…]